BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 22772155)

  • 21. The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential.
    Nabel CS; Manning SA; Kohli RM
    ACS Chem Biol; 2012 Jan; 7(1):20-30. PubMed ID: 22004246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBECs orchestrate genomic and epigenomic editing across health and disease.
    Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
    Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
    Knisbacher BA; Gerber D; Levanon EY
    Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
    Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
    Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
    Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
    Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatic approaches for profiling cytosine methylation and hydroxymethylation.
    Wang T; Loo CE; Kohli RM
    Mol Metab; 2022 Mar; 57():101314. PubMed ID: 34375743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AID enzymatic activity is inversely proportional to the size of cytosine C5 orbital cloud.
    Rangam G; Schmitz KM; Cobb AJ; Petersen-Mahrt SK
    PLoS One; 2012; 7(8):e43279. PubMed ID: 22916236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA demethylation dynamics.
    Bhutani N; Burns DM; Blau HM
    Cell; 2011 Sep; 146(6):866-72. PubMed ID: 21925312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advantages and disadvantages of cytidine deamination.
    Cascalho M
    J Immunol; 2004 Jun; 172(11):6513-8. PubMed ID: 15153462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
    Krokan HE; Sætrom P; Aas PA; Pettersen HS; Kavli B; Slupphaug G
    DNA Repair (Amst); 2014 Jul; 19():38-47. PubMed ID: 24746924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.
    Carpenter MA; Li M; Rathore A; Lackey L; Law EK; Land AM; Leonard B; Shandilya SM; Bohn MF; Schiffer CA; Brown WL; Harris RS
    J Biol Chem; 2012 Oct; 287(41):34801-8. PubMed ID: 22896697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dancin' deaminase.
    Harris RS; Matsuo H
    Nat Struct Mol Biol; 2006 May; 13(5):380-1. PubMed ID: 16738602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of Genomic Alteration from Cytidine Deamination.
    Liu X; Meng FL
    Adv Exp Med Biol; 2018; 1044():49-64. PubMed ID: 29956291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk between genetic and epigenetic information through cytosine deamination.
    Chahwan R; Wontakal SN; Roa S
    Trends Genet; 2010 Oct; 26(10):443-8. PubMed ID: 20800313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
    Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity.
    Franchini DM; Petersen-Mahrt SK
    Epigenomics; 2014; 6(4):427-43. PubMed ID: 25333851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral restriction by APOBEC proteins.
    Harris RS; Liddament MT
    Nat Rev Immunol; 2004 Nov; 4(11):868-77. PubMed ID: 15516966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.